632352-74-0

Usage

Molecular Structure

A piperidinone derivative with a BOC protecting group and a fluorophenyl substituent at the 3-position of the piperidinone ring.

Usage

Commonly used in the synthesis of pharmaceuticals and in medicinal chemistry research.

Importance in Drug Discovery

Potential pharmacological activity and ability to be modified into various derivatives with diverse biological properties.

Medical Applications

Shown promising results in the treatment of various diseases and conditions, making it an important chemical in the field of medicinal chemistry.

Upstream product

• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 460-00-4 1-Bromo-4-fluorobenzene 
• 587-88-2 ethyl 2-(4-fluorophenyl)acetate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1263870-41-2 ethyl 3-((3-ethoxy-3-oxopropyl)amino)-2-(4-fluorophenyl)propanoate 

Downstream Products

• 923281-90-7 C₂₄H₃₁FN₂O₂ 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUND

The present invention relates to N-((3S,4R)-1-((8-chloroquinoxalin-6-yl)carbonyl)-3-(4-fluorophenyl)piperidin-4-yl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole-3-carboxamide, which is a compound that can be useful for the treatment or prevention of SPT-related diseases including congenital diseases associated with the storage of sphingolipids, such as cancer and Niemann-Pick disease, or a salt thereof.

HETEROCYCLIC COMPOUND

The present invention relates to a compound which can be useful for the treatment or prevention of SPT-related diseases including cancer and congenital diseases associated with sphingolipid accumulation (including Niemann-Pick disease).

FUSED TRIAZOLE TACHYKININ RECEPTOR ANTAGONISTS

The present invention is directed to certain fused triazole compounds which are useful as neurokinin-1 (NK-I) receptor antagonists, and inhibitors of tachykinin and in particular substance P- The invention is also concerned with pharmaceutical formulation

CYCLOALKYL KETO PIPERIDINE TACHYKININ RECEPTOR ANTAGONISTS

The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations co

PIPERIDINYL PIPERIDINE TACHYKININ RECEPTOR ANTAGONISTS

The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations co

CYCLOALKYL PIPERIDINE TACHYKININ RECEPTOR ANTAGONISTS

The present invention is directed to certain piperidine compounds which are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The invention is also concerned with pharmaceutical formulations co

PIPERIDINE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE

The present invention provides a compound represented by the formula: ???wherein Ar is an aryl group, an aralkyl group or an aromatic heterocyclic group, each of which may be substituted, R1 is a hydrogen atom, an optionally substituted hydroca